Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 29, 2021 - Issue 3
Submit an article Journal homepage
271
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Serial Detection of MYD88 L265P Mutation in the Aqueous Humor of a Patient with Vitreoretinal Lymphoma for Disease Monitoring

Seonghee Choia Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information
, MD,
Saeam Shinb Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information
, MD,
Seung-Tae Leeb Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information
, MD, PhD,
Junwon Leea Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information
, MD, PhD,
Jihei Sara Leea Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information
, MD,
Borahm Kimb Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information
, MD &
Christopher Seungkyu Leea Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5054-9470View further author information
, MD, PhDORCID Icon show all
Pages 485-489 | Received 31 Mar 2020, Accepted 24 Jul 2020, Published online: 23 Sep 2020

References

  • Mehta M, Rasheed RA, Duker J, et al. Vitreous evaluation: A diagnostic challenge. Ophthalmology. 2015;122:531–537. doi:10.1016/j.ophtha.2014.09.016.
  • Bonzheim I, Giese S, Deuter C, et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood. 2015;126:76–79. doi:10.1182/blood-2015-01-620518.
  • Lee J, Kim B, Lee H, et al. Whole exome sequencing identifies mutational signatures of vitreoretinal lymphoma. Haematologica. 2020:haematol.2019.233783. doi:10.3324/haematol.2019.233783.
  • Miserocchi E, Ferreri AJM, Giuffre C, et al. Myd88 L265p mutation detection in the aqueous humor of patients with vitreoretinal lymphoma. Retina. 2019;39:679–684. doi:10.1097/IAE.0000000000002319.
  • Roschewski M, Dunleavy K, Pittaluga S, et al. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: A correlative biomarker study. Lancet Oncol. 2015;16:541–549. doi:10.1016/S1470-2045(15)70106-3.
  • Kurtz DM, Green MR, Bratman SV, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015;125:3679–3687. doi:10.1182/blood-2015-03-635169.
  • Group SoUNW. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057.
  • Rainen L, Arbique J, Asthana D, et al. Clinical Laboratory Standards Institute Document MM13-A: Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods Approved Guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
  • Lee S-T, Kim J-Y, Kown M-J, et al. Mutant enrichment with 3′-modified oligonucleotides: a practical PCR method for detecting trace mutant DNAs. J Mol Diagn. 2011;13:657–668. doi:10.1016/j.jmoldx.2011.07.003.
  • Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109:1709–1716. doi:10.1016/S0161-6420(02)01125-9.
  • Cicinelli MV, Marchese A, Miserocchi E, et al. Retinal and choroidal changes of vitreoretinal lymphoma from active to remission phase after intravitreal rituximab. Ocul Immunol Inflamm. 2020;28:637–646. doi:10.1080/09273948.2019.1616769.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.